US FDA's Delay In Acting On Moderna RSV Vaccine Adds To Growing List of User Fee Goal Misses

 
• By Bridget Silverman
  
delay
Missed user fee goal date are becoming more common place for novel products. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards